Product news

Share this article:
Teva said the FDA approved its generic version of Procter & Gamble Actonel (risedronate sodium tablets) in 5 mg, 30 mg and 35 mg doses to treat and prevent postmenopausal and glucocorticoid-induced osteoporosis, and to treat Paget's disease. Actonel had US sales of about $1 billion, for the 12 months ended June 30, based on IMS sales data.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.